Listen to this exciting update about the biggest treatment developments for biologics, oral agents and topicals for psoriasis and psoriatic arthritis. Leading dermatologist Dr. Andrew Blauvelt, President of Oregon Medical Research Center in Portland shares clinical results, pathways, and why he's excited about such developments! This activity is supported by unrestricted educational grants from Amgen, Bristol Myers Squibb, Janssen and Novartis.
